trial

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia

NCTId NCT00783120
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 197 (actual)
Sponsored by Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
Primary completion 2011-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
197 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2008-01
Primary completion
2011-08
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
repetitive Transcranial Magnetic Stimulation

Sponsors

Institut fuer anwendungsorientierte Forschung und klinische Studien GmbHLead Sponsor
University of GöttingenCollaborator

Investigators

1
Peter G. Falkai, Prof. Dr.Study Director

Sites

3 total
Regensburg, GermanyGöttingen, GermanyDüsseldorf, Germany

Facts & assertions

4 sourced
Enrollment
197
Phase
NA
Primary Completion Date
2011-08
Status
COMPLETED
relationships
The graph out of here
drug
repetitive Transcranial Magnetic Stimulation
drug
lead_sponsor
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
company
collaborator
University of Göttingen
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Peter G. Falkai, Prof. Dr.
person